Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Supply, Demand and Key Producers, 2026-2032
The global Continuous Glucose Monitoring (CGM) System for Diabetes Management market size is expected to reach $ 30555 million by 2032, rising at a market growth of 10.7% CAGR during the forecast period (2026-2032).
A continuous glucose monitoring system is a medical device and data-enabled care solution for diabetes management. It measures glucose levels continuously by placing a disposable sensor in the subcutaneous interstitial space, converting biochemical signals into time-series glucose readings, and presenting trends, rate-of-change insights, and alerts for high and low glucose events. A typical system includes a sensor, a signal transmission module, and a display endpoint such as a dedicated receiver or a mobile application, supported by analytics and reporting functions that facilitate therapy adjustment and follow-up care.
In terms of form factor, the mainstream product is a patch-worn wearable sensor. By usage mode, products commonly fall into real-time systems that automatically present readings and alerts and scan-based systems that require user-initiated checks, with a smaller segment of implantable long-wear options. The core value lies in transforming episodic point testing into continuous visibility of glucose dynamics, enabling earlier risk detection, more informed dosing and lifestyle decisions, and standardized metrics for long-term glycemic evaluation across diverse care settings.
In 2025, annual global shipments of continuous glucose monitoring (CGM) systems for diabetes management were estimated at approximately 1.6?2.4 million units. On an ex-factory basis (a practical proxy for FOB net selling value), the first-year ex-factory value per system typically ranged from around USD 900 to 1,400 per system.
Driven by the rising global diabetes burden and the shift toward more proactive glycemic control, continuous glucose monitoring systems are evolving from niche tools for highly engaged users into foundational infrastructure for broader chronic care. Continuous trend visibility and real-time risk alerts improve day-to-day decision making, increase patient engagement, and provide a scalable data backbone for clinical follow-up and remote care models. As wear comfort improves and wear duration extends, factory calibration and simplified onboarding are lowering adoption barriers. Market expansion is moving beyond type 1 diabetes into insulin-treated type 2 diabetes, and in certain markets further into wider type 2 populations where providers and payers recognize the value of preventing deterioration and acute events.
Challenges Risks and Demand Trends
Key uncertainties center on product reliability and manufacturing scalability, reimbursement and channel dynamics, and data ecosystem integration. Any quality disruption can quickly translate into safety concerns regulatory exposure and loss of trust, forcing manufacturers to sustain investment in process control and supply resilience. At the same time, intensifying competition and channel shifts toward pharmacy distribution can reshape pricing and margin profiles. On the demand side, interoperability is becoming a defining expectation as monitoring increasingly connects with insulin delivery, automated therapy workflows, and out-of-hospital digital follow-up. Buyers are raising requirements for accuracy consistency and alert performance while relying more on analytics that translate data into actionable guidance. Competition is therefore expanding from hardware specs to a combined play of algorithms ecosystem compatibility and service efficiency.
This report studies the global Continuous Glucose Monitoring (CGM) System for Diabetes Management production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Continuous Glucose Monitoring (CGM) System for Diabetes Management and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Continuous Glucose Monitoring (CGM) System for Diabetes Management that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management total production and demand, 2021-2032, (K Units)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management total production value, 2021-2032, (USD Million)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management domestic production, consumption, key domestic manufacturers and share
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, DexCom, Inc., Medtronic plc, Senseonics Holdings, Inc., Nemaura Medical Inc., A. Menarini Diagnostics S.r.l., Sinocare Inc., Medtrum Technologies Inc., MicroTech Medical (Hangzhou) Co., Ltd., SiBionics (Shenzhen) Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Continuous Glucose Monitoring (CGM) System for Diabetes Management market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market, By Region:
1. How big is the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
2. What is the demand of the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
3. What is the year over year growth of the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
4. What is the production and production value of the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
5. Who are the key producers in the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
6. What are the growth factors driving the market demand?
A continuous glucose monitoring system is a medical device and data-enabled care solution for diabetes management. It measures glucose levels continuously by placing a disposable sensor in the subcutaneous interstitial space, converting biochemical signals into time-series glucose readings, and presenting trends, rate-of-change insights, and alerts for high and low glucose events. A typical system includes a sensor, a signal transmission module, and a display endpoint such as a dedicated receiver or a mobile application, supported by analytics and reporting functions that facilitate therapy adjustment and follow-up care.
In terms of form factor, the mainstream product is a patch-worn wearable sensor. By usage mode, products commonly fall into real-time systems that automatically present readings and alerts and scan-based systems that require user-initiated checks, with a smaller segment of implantable long-wear options. The core value lies in transforming episodic point testing into continuous visibility of glucose dynamics, enabling earlier risk detection, more informed dosing and lifestyle decisions, and standardized metrics for long-term glycemic evaluation across diverse care settings.
In 2025, annual global shipments of continuous glucose monitoring (CGM) systems for diabetes management were estimated at approximately 1.6?2.4 million units. On an ex-factory basis (a practical proxy for FOB net selling value), the first-year ex-factory value per system typically ranged from around USD 900 to 1,400 per system.
Driven by the rising global diabetes burden and the shift toward more proactive glycemic control, continuous glucose monitoring systems are evolving from niche tools for highly engaged users into foundational infrastructure for broader chronic care. Continuous trend visibility and real-time risk alerts improve day-to-day decision making, increase patient engagement, and provide a scalable data backbone for clinical follow-up and remote care models. As wear comfort improves and wear duration extends, factory calibration and simplified onboarding are lowering adoption barriers. Market expansion is moving beyond type 1 diabetes into insulin-treated type 2 diabetes, and in certain markets further into wider type 2 populations where providers and payers recognize the value of preventing deterioration and acute events.
Challenges Risks and Demand Trends
Key uncertainties center on product reliability and manufacturing scalability, reimbursement and channel dynamics, and data ecosystem integration. Any quality disruption can quickly translate into safety concerns regulatory exposure and loss of trust, forcing manufacturers to sustain investment in process control and supply resilience. At the same time, intensifying competition and channel shifts toward pharmacy distribution can reshape pricing and margin profiles. On the demand side, interoperability is becoming a defining expectation as monitoring increasingly connects with insulin delivery, automated therapy workflows, and out-of-hospital digital follow-up. Buyers are raising requirements for accuracy consistency and alert performance while relying more on analytics that translate data into actionable guidance. Competition is therefore expanding from hardware specs to a combined play of algorithms ecosystem compatibility and service efficiency.
This report studies the global Continuous Glucose Monitoring (CGM) System for Diabetes Management production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Continuous Glucose Monitoring (CGM) System for Diabetes Management and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Continuous Glucose Monitoring (CGM) System for Diabetes Management that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management total production and demand, 2021-2032, (K Units)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management total production value, 2021-2032, (USD Million)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management domestic production, consumption, key domestic manufacturers and share
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, DexCom, Inc., Medtronic plc, Senseonics Holdings, Inc., Nemaura Medical Inc., A. Menarini Diagnostics S.r.l., Sinocare Inc., Medtrum Technologies Inc., MicroTech Medical (Hangzhou) Co., Ltd., SiBionics (Shenzhen) Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Continuous Glucose Monitoring (CGM) System for Diabetes Management market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Patch Based Wearable Sensor
- Implantable Sensor
- Others
- Intermittently Scanned CGM
- Real Time CGM
- Implantable CGM
- Intensive Insulin Therapy
- Basal Insulin Therapy
- Non Insulin Diabetes Management
- Retail Pharmacy Channel
- DME and Distributor Channel
- Hospital Procurement Channel
- Home and Ambulatory Care
- Outpatient Clinic Follow Up
- Inpatient Glycemic Management
- Abbott Laboratories
- DexCom, Inc.
- Medtronic plc
- Senseonics Holdings, Inc.
- Nemaura Medical Inc.
- A. Menarini Diagnostics S.r.l.
- Sinocare Inc.
- Medtrum Technologies Inc.
- MicroTech Medical (Hangzhou) Co., Ltd.
- SiBionics (Shenzhen) Co., Ltd.
- Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
1. How big is the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
2. What is the demand of the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
3. What is the year over year growth of the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
4. What is the production and production value of the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
5. Who are the key producers in the global Continuous Glucose Monitoring (CGM) System for Diabetes Management market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Introduction
1.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Supply & Forecast
1.2.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value (2021 & 2025 & 2032)
1.2.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.2.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Pricing Trends (2021-2032)
1.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Region (Based on Production Site)
1.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Region (2021-2032)
1.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Region (2021-2032)
1.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Region (2021-2032)
1.3.4 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.3.5 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.3.6 China Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.3.7 Southeast Asia Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Major Market Trends
2 DEMAND SUMMARY
2.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Demand (2021-2032)
2.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption by Region
2.2.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption by Region (2021-2026)
2.2.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Forecast by Region (2027-2032)
2.3 United States Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.4 China Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.5 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.6 Japan Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.7 South Korea Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.8 ASEAN Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.9 India Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Manufacturer (2021-2026)
3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Manufacturer (2021-2026)
3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Manufacturer (2021-2026)
3.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Continuous Glucose Monitoring (CGM) System for Diabetes Management in 2025
3.5.3 Global Concentration Ratios (CR8) for Continuous Glucose Monitoring (CGM) System for Diabetes Management in 2025
3.6 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Overall Company Footprint Analysis
3.6.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Region Footprint
3.6.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Company Product Type Footprint
3.6.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Comparison
4.1.1 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Comparison
4.2.1 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Comparison
4.3.1 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value (2021-2026)
4.4.3 United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2026)
4.5 China Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers and Market Share
4.5.1 China Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value (2021-2026)
4.5.3 China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2026)
4.6 Rest of World Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Patch Based Wearable Sensor
5.2.2 Implantable Sensor
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Type (2021-2032)
5.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type (2021-2032)
5.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MONITORING MODE
6.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Monitoring Mode: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Monitoring Mode
6.2.1 Intermittently Scanned CGM
6.2.2 Real Time CGM
6.2.3 Implantable CGM
6.3 Market Segment by Monitoring Mode
6.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Monitoring Mode (2021-2032)
6.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode (2021-2032)
6.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Monitoring Mode (2021-2032)
7 MARKET ANALYSIS BY PATIENT THERAPY INTENSITY
7.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Patient Therapy Intensity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Patient Therapy Intensity
7.2.1 Intensive Insulin Therapy
7.2.2 Basal Insulin Therapy
7.2.3 Non Insulin Diabetes Management
7.3 Market Segment by Patient Therapy Intensity
7.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Patient Therapy Intensity (2021-2032)
7.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity (2021-2032)
7.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Patient Therapy Intensity (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNEL
8.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channel
8.2.1 Retail Pharmacy Channel
8.2.2 DME and Distributor Channel
8.2.3 Hospital Procurement Channel
8.3 Market Segment by Sales Channel
8.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Sales Channel (2021-2032)
8.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel (2021-2032)
8.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Sales Channel (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Home and Ambulatory Care
9.2.2 Outpatient Clinic Follow Up
9.2.3 Inpatient Glycemic Management
9.3 Market Segment by Application
9.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Application (2021-2032)
9.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application (2021-2032)
9.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Details
10.1.2 Abbott Laboratories Major Business
10.1.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.1.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Abbott Laboratories Recent Developments/Updates
10.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
10.2 DexCom, Inc.
10.2.1 DexCom, Inc. Details
10.2.2 DexCom, Inc. Major Business
10.2.3 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.2.4 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 DexCom, Inc. Recent Developments/Updates
10.2.6 DexCom, Inc. Competitive Strengths & Weaknesses
10.3 Medtronic plc
10.3.1 Medtronic plc Details
10.3.2 Medtronic plc Major Business
10.3.3 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.3.4 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Medtronic plc Recent Developments/Updates
10.3.6 Medtronic plc Competitive Strengths & Weaknesses
10.4 Senseonics Holdings, Inc.
10.4.1 Senseonics Holdings, Inc. Details
10.4.2 Senseonics Holdings, Inc. Major Business
10.4.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.4.4 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Senseonics Holdings, Inc. Recent Developments/Updates
10.4.6 Senseonics Holdings, Inc. Competitive Strengths & Weaknesses
10.5 Nemaura Medical Inc.
10.5.1 Nemaura Medical Inc. Details
10.5.2 Nemaura Medical Inc. Major Business
10.5.3 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.5.4 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Nemaura Medical Inc. Recent Developments/Updates
10.5.6 Nemaura Medical Inc. Competitive Strengths & Weaknesses
10.6 A. Menarini Diagnostics S.r.l.
10.6.1 A. Menarini Diagnostics S.r.l. Details
10.6.2 A. Menarini Diagnostics S.r.l. Major Business
10.6.3 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.6.4 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 A. Menarini Diagnostics S.r.l. Recent Developments/Updates
10.6.6 A. Menarini Diagnostics S.r.l. Competitive Strengths & Weaknesses
10.7 Sinocare Inc.
10.7.1 Sinocare Inc. Details
10.7.2 Sinocare Inc. Major Business
10.7.3 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.7.4 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Sinocare Inc. Recent Developments/Updates
10.7.6 Sinocare Inc. Competitive Strengths & Weaknesses
10.8 Medtrum Technologies Inc.
10.8.1 Medtrum Technologies Inc. Details
10.8.2 Medtrum Technologies Inc. Major Business
10.8.3 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.8.4 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Medtrum Technologies Inc. Recent Developments/Updates
10.8.6 Medtrum Technologies Inc. Competitive Strengths & Weaknesses
10.9 MicroTech Medical (Hangzhou) Co., Ltd.
10.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Details
10.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Major Business
10.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
10.9.6 MicroTech Medical (Hangzhou) Co., Ltd. Competitive Strengths & Weaknesses
10.10 SiBionics (Shenzhen) Co., Ltd.
10.10.1 SiBionics (Shenzhen) Co., Ltd. Details
10.10.2 SiBionics (Shenzhen) Co., Ltd. Major Business
10.10.3 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.10.4 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 SiBionics (Shenzhen) Co., Ltd. Recent Developments/Updates
10.10.6 SiBionics (Shenzhen) Co., Ltd. Competitive Strengths & Weaknesses
10.11 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
10.11.1 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Details
10.11.2 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Major Business
10.11.3 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.11.4 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Recent Developments/Updates
10.11.6 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Chain
11.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Upstream Analysis
11.2.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Core Raw Materials
11.2.2 Main Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Mode
11.6 Continuous Glucose Monitoring (CGM) System for Diabetes Management Procurement Model
11.7 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Sales Model and Sales Channels
11.7.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Model
11.7.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Introduction
1.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Supply & Forecast
1.2.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value (2021 & 2025 & 2032)
1.2.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.2.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Pricing Trends (2021-2032)
1.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Region (Based on Production Site)
1.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Region (2021-2032)
1.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Region (2021-2032)
1.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Region (2021-2032)
1.3.4 North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.3.5 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.3.6 China Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.3.7 Southeast Asia Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Major Market Trends
2 DEMAND SUMMARY
2.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Demand (2021-2032)
2.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption by Region
2.2.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption by Region (2021-2026)
2.2.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Forecast by Region (2027-2032)
2.3 United States Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.4 China Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.5 Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.6 Japan Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.7 South Korea Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.8 ASEAN Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
2.9 India Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Manufacturer (2021-2026)
3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Manufacturer (2021-2026)
3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Manufacturer (2021-2026)
3.4 Continuous Glucose Monitoring (CGM) System for Diabetes Management Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Continuous Glucose Monitoring (CGM) System for Diabetes Management in 2025
3.5.3 Global Concentration Ratios (CR8) for Continuous Glucose Monitoring (CGM) System for Diabetes Management in 2025
3.6 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Overall Company Footprint Analysis
3.6.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Region Footprint
3.6.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Company Product Type Footprint
3.6.3 Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Comparison
4.1.1 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Comparison
4.2.1 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Comparison
4.3.1 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value (2021-2026)
4.4.3 United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2026)
4.5 China Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers and Market Share
4.5.1 China Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value (2021-2026)
4.5.3 China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2026)
4.6 Rest of World Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Patch Based Wearable Sensor
5.2.2 Implantable Sensor
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Type (2021-2032)
5.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type (2021-2032)
5.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MONITORING MODE
6.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Monitoring Mode: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Monitoring Mode
6.2.1 Intermittently Scanned CGM
6.2.2 Real Time CGM
6.2.3 Implantable CGM
6.3 Market Segment by Monitoring Mode
6.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Monitoring Mode (2021-2032)
6.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode (2021-2032)
6.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Monitoring Mode (2021-2032)
7 MARKET ANALYSIS BY PATIENT THERAPY INTENSITY
7.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Patient Therapy Intensity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Patient Therapy Intensity
7.2.1 Intensive Insulin Therapy
7.2.2 Basal Insulin Therapy
7.2.3 Non Insulin Diabetes Management
7.3 Market Segment by Patient Therapy Intensity
7.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Patient Therapy Intensity (2021-2032)
7.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity (2021-2032)
7.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Patient Therapy Intensity (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNEL
8.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channel
8.2.1 Retail Pharmacy Channel
8.2.2 DME and Distributor Channel
8.2.3 Hospital Procurement Channel
8.3 Market Segment by Sales Channel
8.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Sales Channel (2021-2032)
8.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel (2021-2032)
8.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Sales Channel (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Home and Ambulatory Care
9.2.2 Outpatient Clinic Follow Up
9.2.3 Inpatient Glycemic Management
9.3 Market Segment by Application
9.3.1 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Application (2021-2032)
9.3.2 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application (2021-2032)
9.3.3 World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Details
10.1.2 Abbott Laboratories Major Business
10.1.3 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.1.4 Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Abbott Laboratories Recent Developments/Updates
10.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
10.2 DexCom, Inc.
10.2.1 DexCom, Inc. Details
10.2.2 DexCom, Inc. Major Business
10.2.3 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.2.4 DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 DexCom, Inc. Recent Developments/Updates
10.2.6 DexCom, Inc. Competitive Strengths & Weaknesses
10.3 Medtronic plc
10.3.1 Medtronic plc Details
10.3.2 Medtronic plc Major Business
10.3.3 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.3.4 Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Medtronic plc Recent Developments/Updates
10.3.6 Medtronic plc Competitive Strengths & Weaknesses
10.4 Senseonics Holdings, Inc.
10.4.1 Senseonics Holdings, Inc. Details
10.4.2 Senseonics Holdings, Inc. Major Business
10.4.3 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.4.4 Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 Senseonics Holdings, Inc. Recent Developments/Updates
10.4.6 Senseonics Holdings, Inc. Competitive Strengths & Weaknesses
10.5 Nemaura Medical Inc.
10.5.1 Nemaura Medical Inc. Details
10.5.2 Nemaura Medical Inc. Major Business
10.5.3 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.5.4 Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Nemaura Medical Inc. Recent Developments/Updates
10.5.6 Nemaura Medical Inc. Competitive Strengths & Weaknesses
10.6 A. Menarini Diagnostics S.r.l.
10.6.1 A. Menarini Diagnostics S.r.l. Details
10.6.2 A. Menarini Diagnostics S.r.l. Major Business
10.6.3 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.6.4 A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 A. Menarini Diagnostics S.r.l. Recent Developments/Updates
10.6.6 A. Menarini Diagnostics S.r.l. Competitive Strengths & Weaknesses
10.7 Sinocare Inc.
10.7.1 Sinocare Inc. Details
10.7.2 Sinocare Inc. Major Business
10.7.3 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.7.4 Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Sinocare Inc. Recent Developments/Updates
10.7.6 Sinocare Inc. Competitive Strengths & Weaknesses
10.8 Medtrum Technologies Inc.
10.8.1 Medtrum Technologies Inc. Details
10.8.2 Medtrum Technologies Inc. Major Business
10.8.3 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.8.4 Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Medtrum Technologies Inc. Recent Developments/Updates
10.8.6 Medtrum Technologies Inc. Competitive Strengths & Weaknesses
10.9 MicroTech Medical (Hangzhou) Co., Ltd.
10.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Details
10.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Major Business
10.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
10.9.6 MicroTech Medical (Hangzhou) Co., Ltd. Competitive Strengths & Weaknesses
10.10 SiBionics (Shenzhen) Co., Ltd.
10.10.1 SiBionics (Shenzhen) Co., Ltd. Details
10.10.2 SiBionics (Shenzhen) Co., Ltd. Major Business
10.10.3 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.10.4 SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 SiBionics (Shenzhen) Co., Ltd. Recent Developments/Updates
10.10.6 SiBionics (Shenzhen) Co., Ltd. Competitive Strengths & Weaknesses
10.11 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
10.11.1 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Details
10.11.2 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Major Business
10.11.3 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
10.11.4 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Recent Developments/Updates
10.11.6 Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Chain
11.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Upstream Analysis
11.2.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Core Raw Materials
11.2.2 Main Manufacturers of Continuous Glucose Monitoring (CGM) System for Diabetes Management Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Mode
11.6 Continuous Glucose Monitoring (CGM) System for Diabetes Management Procurement Model
11.7 Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Sales Model and Sales Channels
11.7.1 Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Model
11.7.2 Continuous Glucose Monitoring (CGM) System for Diabetes Management Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Region (2021-2026) & (USD Million)
Table 3. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Region (2027-2032) & (USD Million)
Table 4. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Region (2021-2026)
Table 5. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Region (2027-2032)
Table 6. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Region (2021-2026) & (K Units)
Table 7. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Region (2027-2032) & (K Units)
Table 8. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Region (2021-2026)
Table 9. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Region (2027-2032)
Table 10. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Continuous Glucose Monitoring (CGM) System for Diabetes Management Major Market Trends
Table 13. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption by Region (2021-2026) & (K Units)
Table 15. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Continuous Glucose Monitoring (CGM) System for Diabetes Management Producers in 2025
Table 18. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Continuous Glucose Monitoring (CGM) System for Diabetes Management Producers in 2025
Table 20. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Company Evaluation Quadrant
Table 22. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Site of Key Manufacturer
Table 24. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Company Product Type Footprint
Table 25. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Company Product Application Footprint
Table 26. Continuous Glucose Monitoring (CGM) System for Diabetes Management Competitive Factors
Table 27. Continuous Glucose Monitoring (CGM) System for Diabetes Management New Entrant and Capacity Expansion Plans
Table 28. Continuous Glucose Monitoring (CGM) System for Diabetes Management Mergers & Acquisitions Activity
Table 29. United States VS China Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share (2021-2026)
Table 37. China Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share (2021-2026)
Table 42. Rest of World Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share (2021-2026)
Table 47. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Type (2021-2026) & (K Units)
Table 49. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Type (2027-2032) & (K Units)
Table 50. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type (2021-2026) & (USD Million)
Table 51. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type (2027-2032) & (USD Million)
Table 52. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode, (USD Million), 2021 & 2025 & 2032
Table 55. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Monitoring Mode (2021-2026) & (K Units)
Table 56. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Monitoring Mode (2027-2032) & (K Units)
Table 57. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode (2021-2026) & (USD Million)
Table 58. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode (2027-2032) & (USD Million)
Table 59. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Monitoring Mode (2021-2026) & (US$/Unit)
Table 60. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Monitoring Mode (2027-2032) & (US$/Unit)
Table 61. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity, (USD Million), 2021 & 2025 & 2032
Table 62. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Patient Therapy Intensity (2021-2026) & (K Units)
Table 63. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Patient Therapy Intensity (2027-2032) & (K Units)
Table 64. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity (2021-2026) & (USD Million)
Table 65. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity (2027-2032) & (USD Million)
Table 66. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Patient Therapy Intensity (2021-2026) & (US$/Unit)
Table 67. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Patient Therapy Intensity (2027-2032) & (US$/Unit)
Table 68. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 69. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Sales Channel (2021-2026) & (K Units)
Table 70. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Sales Channel (2027-2032) & (K Units)
Table 71. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel (2021-2026) & (USD Million)
Table 72. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel (2027-2032) & (USD Million)
Table 73. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 74. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 75. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Application (2021-2026) & (K Units)
Table 77. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Application (2027-2032) & (K Units)
Table 78. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application (2021-2026) & (USD Million)
Table 79. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application (2027-2032) & (USD Million)
Table 80. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 83. Abbott Laboratories Major Business
Table 84. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 85. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Abbott Laboratories Recent Developments/Updates
Table 87. Abbott Laboratories Competitive Strengths & Weaknesses
Table 88. DexCom, Inc. Basic Information, Manufacturing Base and Competitors
Table 89. DexCom, Inc. Major Business
Table 90. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 91. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. DexCom, Inc. Recent Developments/Updates
Table 93. DexCom, Inc. Competitive Strengths & Weaknesses
Table 94. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 95. Medtronic plc Major Business
Table 96. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 97. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Medtronic plc Recent Developments/Updates
Table 99. Medtronic plc Competitive Strengths & Weaknesses
Table 100. Senseonics Holdings, Inc. Basic Information, Manufacturing Base and Competitors
Table 101. Senseonics Holdings, Inc. Major Business
Table 102. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 103. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Senseonics Holdings, Inc. Recent Developments/Updates
Table 105. Senseonics Holdings, Inc. Competitive Strengths & Weaknesses
Table 106. Nemaura Medical Inc. Basic Information, Manufacturing Base and Competitors
Table 107. Nemaura Medical Inc. Major Business
Table 108. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 109. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Nemaura Medical Inc. Recent Developments/Updates
Table 111. Nemaura Medical Inc. Competitive Strengths & Weaknesses
Table 112. A. Menarini Diagnostics S.r.l. Basic Information, Manufacturing Base and Competitors
Table 113. A. Menarini Diagnostics S.r.l. Major Business
Table 114. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 115. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. A. Menarini Diagnostics S.r.l. Recent Developments/Updates
Table 117. A. Menarini Diagnostics S.r.l. Competitive Strengths & Weaknesses
Table 118. Sinocare Inc. Basic Information, Manufacturing Base and Competitors
Table 119. Sinocare Inc. Major Business
Table 120. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 121. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Sinocare Inc. Recent Developments/Updates
Table 123. Sinocare Inc. Competitive Strengths & Weaknesses
Table 124. Medtrum Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 125. Medtrum Technologies Inc. Major Business
Table 126. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 127. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Medtrum Technologies Inc. Recent Developments/Updates
Table 129. Medtrum Technologies Inc. Competitive Strengths & Weaknesses
Table 130. MicroTech Medical (Hangzhou) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 131. MicroTech Medical (Hangzhou) Co., Ltd. Major Business
Table 132. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 133. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
Table 135. MicroTech Medical (Hangzhou) Co., Ltd. Competitive Strengths & Weaknesses
Table 136. SiBionics (Shenzhen) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 137. SiBionics (Shenzhen) Co., Ltd. Major Business
Table 138. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 139. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. SiBionics (Shenzhen) Co., Ltd. Recent Developments/Updates
Table 141. SiBionics (Shenzhen) Co., Ltd. Competitive Strengths & Weaknesses
Table 142. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 143. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Major Business
Table 144. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 145. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Recent Developments/Updates
Table 147. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Competitive Strengths & Weaknesses
Table 148. Global Key Players of Continuous Glucose Monitoring (CGM) System for Diabetes Management Upstream (Raw Materials)
Table 149. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Typical Customers
Table 150. Continuous Glucose Monitoring (CGM) System for Diabetes Management Typical Distributors
Table 1. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Region (2021-2026) & (USD Million)
Table 3. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Region (2027-2032) & (USD Million)
Table 4. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Region (2021-2026)
Table 5. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Region (2027-2032)
Table 6. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Region (2021-2026) & (K Units)
Table 7. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Region (2027-2032) & (K Units)
Table 8. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Region (2021-2026)
Table 9. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Region (2027-2032)
Table 10. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Continuous Glucose Monitoring (CGM) System for Diabetes Management Major Market Trends
Table 13. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption by Region (2021-2026) & (K Units)
Table 15. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Continuous Glucose Monitoring (CGM) System for Diabetes Management Producers in 2025
Table 18. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Continuous Glucose Monitoring (CGM) System for Diabetes Management Producers in 2025
Table 20. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Company Evaluation Quadrant
Table 22. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Site of Key Manufacturer
Table 24. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Company Product Type Footprint
Table 25. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market: Company Product Application Footprint
Table 26. Continuous Glucose Monitoring (CGM) System for Diabetes Management Competitive Factors
Table 27. Continuous Glucose Monitoring (CGM) System for Diabetes Management New Entrant and Capacity Expansion Plans
Table 28. Continuous Glucose Monitoring (CGM) System for Diabetes Management Mergers & Acquisitions Activity
Table 29. United States VS China Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share (2021-2026)
Table 37. China Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share (2021-2026)
Table 42. Rest of World Based Continuous Glucose Monitoring (CGM) System for Diabetes Management Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share (2021-2026)
Table 47. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Type (2021-2026) & (K Units)
Table 49. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Type (2027-2032) & (K Units)
Table 50. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type (2021-2026) & (USD Million)
Table 51. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type (2027-2032) & (USD Million)
Table 52. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode, (USD Million), 2021 & 2025 & 2032
Table 55. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Monitoring Mode (2021-2026) & (K Units)
Table 56. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Monitoring Mode (2027-2032) & (K Units)
Table 57. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode (2021-2026) & (USD Million)
Table 58. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode (2027-2032) & (USD Million)
Table 59. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Monitoring Mode (2021-2026) & (US$/Unit)
Table 60. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Monitoring Mode (2027-2032) & (US$/Unit)
Table 61. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity, (USD Million), 2021 & 2025 & 2032
Table 62. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Patient Therapy Intensity (2021-2026) & (K Units)
Table 63. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Patient Therapy Intensity (2027-2032) & (K Units)
Table 64. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity (2021-2026) & (USD Million)
Table 65. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity (2027-2032) & (USD Million)
Table 66. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Patient Therapy Intensity (2021-2026) & (US$/Unit)
Table 67. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Patient Therapy Intensity (2027-2032) & (US$/Unit)
Table 68. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Table 69. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Sales Channel (2021-2026) & (K Units)
Table 70. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Sales Channel (2027-2032) & (K Units)
Table 71. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel (2021-2026) & (USD Million)
Table 72. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel (2027-2032) & (USD Million)
Table 73. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Sales Channel (2021-2026) & (US$/Unit)
Table 74. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Sales Channel (2027-2032) & (US$/Unit)
Table 75. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Application (2021-2026) & (K Units)
Table 77. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production by Application (2027-2032) & (K Units)
Table 78. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application (2021-2026) & (USD Million)
Table 79. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application (2027-2032) & (USD Million)
Table 80. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 83. Abbott Laboratories Major Business
Table 84. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 85. Abbott Laboratories Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Abbott Laboratories Recent Developments/Updates
Table 87. Abbott Laboratories Competitive Strengths & Weaknesses
Table 88. DexCom, Inc. Basic Information, Manufacturing Base and Competitors
Table 89. DexCom, Inc. Major Business
Table 90. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 91. DexCom, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. DexCom, Inc. Recent Developments/Updates
Table 93. DexCom, Inc. Competitive Strengths & Weaknesses
Table 94. Medtronic plc Basic Information, Manufacturing Base and Competitors
Table 95. Medtronic plc Major Business
Table 96. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 97. Medtronic plc Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Medtronic plc Recent Developments/Updates
Table 99. Medtronic plc Competitive Strengths & Weaknesses
Table 100. Senseonics Holdings, Inc. Basic Information, Manufacturing Base and Competitors
Table 101. Senseonics Holdings, Inc. Major Business
Table 102. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 103. Senseonics Holdings, Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Senseonics Holdings, Inc. Recent Developments/Updates
Table 105. Senseonics Holdings, Inc. Competitive Strengths & Weaknesses
Table 106. Nemaura Medical Inc. Basic Information, Manufacturing Base and Competitors
Table 107. Nemaura Medical Inc. Major Business
Table 108. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 109. Nemaura Medical Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Nemaura Medical Inc. Recent Developments/Updates
Table 111. Nemaura Medical Inc. Competitive Strengths & Weaknesses
Table 112. A. Menarini Diagnostics S.r.l. Basic Information, Manufacturing Base and Competitors
Table 113. A. Menarini Diagnostics S.r.l. Major Business
Table 114. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 115. A. Menarini Diagnostics S.r.l. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. A. Menarini Diagnostics S.r.l. Recent Developments/Updates
Table 117. A. Menarini Diagnostics S.r.l. Competitive Strengths & Weaknesses
Table 118. Sinocare Inc. Basic Information, Manufacturing Base and Competitors
Table 119. Sinocare Inc. Major Business
Table 120. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 121. Sinocare Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Sinocare Inc. Recent Developments/Updates
Table 123. Sinocare Inc. Competitive Strengths & Weaknesses
Table 124. Medtrum Technologies Inc. Basic Information, Manufacturing Base and Competitors
Table 125. Medtrum Technologies Inc. Major Business
Table 126. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 127. Medtrum Technologies Inc. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Medtrum Technologies Inc. Recent Developments/Updates
Table 129. Medtrum Technologies Inc. Competitive Strengths & Weaknesses
Table 130. MicroTech Medical (Hangzhou) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 131. MicroTech Medical (Hangzhou) Co., Ltd. Major Business
Table 132. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 133. MicroTech Medical (Hangzhou) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
Table 135. MicroTech Medical (Hangzhou) Co., Ltd. Competitive Strengths & Weaknesses
Table 136. SiBionics (Shenzhen) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 137. SiBionics (Shenzhen) Co., Ltd. Major Business
Table 138. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 139. SiBionics (Shenzhen) Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. SiBionics (Shenzhen) Co., Ltd. Recent Developments/Updates
Table 141. SiBionics (Shenzhen) Co., Ltd. Competitive Strengths & Weaknesses
Table 142. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 143. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Major Business
Table 144. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Product and Services
Table 145. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Recent Developments/Updates
Table 147. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. Competitive Strengths & Weaknesses
Table 148. Global Key Players of Continuous Glucose Monitoring (CGM) System for Diabetes Management Upstream (Raw Materials)
Table 149. Global Continuous Glucose Monitoring (CGM) System for Diabetes Management Typical Customers
Table 150. Continuous Glucose Monitoring (CGM) System for Diabetes Management Typical Distributors
LIST OF FIGURES
Figure 1. Continuous Glucose Monitoring (CGM) System for Diabetes Management Picture
Figure 2. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 5. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price (2021-2032) & (US$/Unit)
Figure 6. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Region (2021-2032)
Figure 7. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Region (2021-2032)
Figure 8. North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 9. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 10. China Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 11. Southeast Asia Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 12. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 15. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Market Share by Region (2021-2032)
Figure 16. United States Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 17. China Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 18. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 19. Japan Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 20. South Korea Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 22. India Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Continuous Glucose Monitoring (CGM) System for Diabetes Management Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Continuous Glucose Monitoring (CGM) System for Diabetes Management Markets in 2025
Figure 26. United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share 2025
Figure 30. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share 2025
Figure 32. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Type in 2025
Figure 34. Patch Based Wearable Sensor
Figure 35. Implantable Sensor
Figure 36. Others
Figure 37. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Type (2021-2032)
Figure 38. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Type (2021-2032)
Figure 39. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode, (USD Million), 2021 & 2025 & 2032
Figure 41. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Monitoring Mode in 2025
Figure 42. Intermittently Scanned CGM
Figure 43. Real Time CGM
Figure 44. Implantable CGM
Figure 45. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Monitoring Mode (2021-2032)
Figure 46. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Monitoring Mode (2021-2032)
Figure 47. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Monitoring Mode (2021-2032) & (US$/Unit)
Figure 48. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity, (USD Million), 2021 & 2025 & 2032
Figure 49. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Patient Therapy Intensity in 2025
Figure 50. Intensive Insulin Therapy
Figure 51. Basal Insulin Therapy
Figure 52. Non Insulin Diabetes Management
Figure 53. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Patient Therapy Intensity (2021-2032)
Figure 54. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Patient Therapy Intensity (2021-2032)
Figure 55. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Patient Therapy Intensity (2021-2032) & (US$/Unit)
Figure 56. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 57. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Sales Channel in 2025
Figure 58. Retail Pharmacy Channel
Figure 59. DME and Distributor Channel
Figure 60. Hospital Procurement Channel
Figure 61. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Sales Channel (2021-2032)
Figure 62. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Sales Channel (2021-2032)
Figure 63. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 64. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 65. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Application in 2025
Figure 66. Home and Ambulatory Care
Figure 67. Outpatient Clinic Follow Up
Figure 68. Inpatient Glycemic Management
Figure 69. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Application (2021-2032)
Figure 70. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Application (2021-2032)
Figure 71. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Application (2021-2032) & (US$/Unit)
Figure 72. Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Chain
Figure 73. Continuous Glucose Monitoring (CGM) System for Diabetes Management Procurement Model
Figure 74. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Model
Figure 75. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Channels, Direct Sales, and Distribution
Figure 76. Methodology
Figure 77. Research Process and Data Source
Figure 1. Continuous Glucose Monitoring (CGM) System for Diabetes Management Picture
Figure 2. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 5. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price (2021-2032) & (US$/Unit)
Figure 6. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Region (2021-2032)
Figure 7. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Region (2021-2032)
Figure 8. North America Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 9. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 10. China Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 11. Southeast Asia Continuous Glucose Monitoring (CGM) System for Diabetes Management Production (2021-2032) & (K Units)
Figure 12. Continuous Glucose Monitoring (CGM) System for Diabetes Management Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 15. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Market Share by Region (2021-2032)
Figure 16. United States Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 17. China Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 18. Europe Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 19. Japan Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 20. South Korea Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 22. India Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Continuous Glucose Monitoring (CGM) System for Diabetes Management by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Continuous Glucose Monitoring (CGM) System for Diabetes Management Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Continuous Glucose Monitoring (CGM) System for Diabetes Management Markets in 2025
Figure 26. United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Continuous Glucose Monitoring (CGM) System for Diabetes Management Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share 2025
Figure 30. China Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share 2025
Figure 32. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Type in 2025
Figure 34. Patch Based Wearable Sensor
Figure 35. Implantable Sensor
Figure 36. Others
Figure 37. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Type (2021-2032)
Figure 38. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Type (2021-2032)
Figure 39. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Monitoring Mode, (USD Million), 2021 & 2025 & 2032
Figure 41. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Monitoring Mode in 2025
Figure 42. Intermittently Scanned CGM
Figure 43. Real Time CGM
Figure 44. Implantable CGM
Figure 45. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Monitoring Mode (2021-2032)
Figure 46. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Monitoring Mode (2021-2032)
Figure 47. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Monitoring Mode (2021-2032) & (US$/Unit)
Figure 48. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Patient Therapy Intensity, (USD Million), 2021 & 2025 & 2032
Figure 49. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Patient Therapy Intensity in 2025
Figure 50. Intensive Insulin Therapy
Figure 51. Basal Insulin Therapy
Figure 52. Non Insulin Diabetes Management
Figure 53. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Patient Therapy Intensity (2021-2032)
Figure 54. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Patient Therapy Intensity (2021-2032)
Figure 55. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Patient Therapy Intensity (2021-2032) & (US$/Unit)
Figure 56. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Sales Channel, (USD Million), 2021 & 2025 & 2032
Figure 57. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Sales Channel in 2025
Figure 58. Retail Pharmacy Channel
Figure 59. DME and Distributor Channel
Figure 60. Hospital Procurement Channel
Figure 61. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Sales Channel (2021-2032)
Figure 62. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Sales Channel (2021-2032)
Figure 63. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Sales Channel (2021-2032) & (US$/Unit)
Figure 64. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 65. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Application in 2025
Figure 66. Home and Ambulatory Care
Figure 67. Outpatient Clinic Follow Up
Figure 68. Inpatient Glycemic Management
Figure 69. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Market Share by Application (2021-2032)
Figure 70. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Production Value Market Share by Application (2021-2032)
Figure 71. World Continuous Glucose Monitoring (CGM) System for Diabetes Management Average Price by Application (2021-2032) & (US$/Unit)
Figure 72. Continuous Glucose Monitoring (CGM) System for Diabetes Management Industry Chain
Figure 73. Continuous Glucose Monitoring (CGM) System for Diabetes Management Procurement Model
Figure 74. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Model
Figure 75. Continuous Glucose Monitoring (CGM) System for Diabetes Management Sales Channels, Direct Sales, and Distribution
Figure 76. Methodology
Figure 77. Research Process and Data Source
